421 related articles for article (PubMed ID: 7956214)
1. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
[TBL] [Abstract][Full Text] [Related]
2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Norris LA; Bonnar J
Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
Akerlund M; Almström E; Högstedt S; Nabrink M
Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
[TBL] [Abstract][Full Text] [Related]
4. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
Nielsen CH; Poulsen HK; Teisner B; Thorsen P; Hau J; Westergaard JG
Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
Basdevant A; Conard J; Pelissier C; Guyene TT; Lapousterle C; Mayer M; Guy-Grand B; Degrelle H
Contraception; 1993 Sep; 48(3):193-204. PubMed ID: 8222650
[TBL] [Abstract][Full Text] [Related]
7. Contraception in older woman.
Volpe A; Silferi M; Genazzani AD; Genazzani AR
Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314
[TBL] [Abstract][Full Text] [Related]
8. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
9. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
10. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
11. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women.
Sirtori CR; Calabresi L; Franceschini G; Gianfranceschi G; Zoppi F; Winkler S; Bilotta P; Zampetti A
Atherosclerosis; 1990 Oct; 84(2-3):203-11. PubMed ID: 2149269
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
[TBL] [Abstract][Full Text] [Related]
14. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Prasad RN; Liew D; Ratnam SS
Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
[TBL] [Abstract][Full Text] [Related]
15. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
[TBL] [Abstract][Full Text] [Related]
16. Changes in androgens during treatment with four low-dose contraceptives.
Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
[TBL] [Abstract][Full Text] [Related]
17. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
Fruzzetti F; Ricci C; Fioretti P
Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
[TBL] [Abstract][Full Text] [Related]
18. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
19. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
[TBL] [Abstract][Full Text] [Related]
20. The effects on hemostasis of oral contraceptives containing desogestrel.
Stubblefield PG
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 2):1047-52. PubMed ID: 8447359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
